Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.
2.

Classification of Marek's disease viruses according to pathotype: philosophy and methodology.

Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA.

Avian Pathol. 2005 Apr;34(2):75-90. Review.

PMID:
16191686
3.

Pathogenesis of Marek's disease virus infection.

Calnek BW.

Curr Top Microbiol Immunol. 2001;255:25-55. No abstract available.

PMID:
11217426
4.

Comparative susceptibility of Marek's disease cell lines to chicken infectious anemia virus.

Calnek BW, Lucio-Martinez B, Cardona C, Harris RW, Schat KA, Buscaglia C.

Avian Dis. 2000 Jan-Mar;44(1):114-24.

PMID:
10737651
5.

Control of avian encephalomyelitis: a historical account.

Calnek BW.

Avian Dis. 1998 Oct-Dec;42(4):632-47. Review.

PMID:
9876829
6.

Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.

Calnek BW, Harris RW, Buscaglia C, Schat KA, Lucio B.

Avian Dis. 1998 Jan-Mar;42(1):124-32.

PMID:
9533089
7.

Interferon modulation of Marek's disease virus genome expression in chicken cell lines.

Volpini LM, Calnek BW, Sneath B, Sekellick MJ, Marcus PI.

Avian Dis. 1996 Jan-Mar;40(1):78-87.

PMID:
8713052
8.

Stages of Marek's disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression.

Volpini LM, Calnek BW, Sekellick MJ, Marcus PI.

Vet Microbiol. 1995 Nov;47(1-2):99-109.

PMID:
8604560
9.

Cytogenetic studies of cell lines derived from Marek's disease virus-induced local lesions.

Moore FR, Calnek BW, Bloom SE.

Avian Dis. 1994 Oct-Dec;38(4):797-9.

PMID:
7702513
10.

Pathologic and serologic characterization of a variant of duck hepatitis type I virus.

Sandhu TS, Calnek BW, Zeman L.

Avian Dis. 1992 Oct-Dec;36(4):932-6.

PMID:
1485876
11.

Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines.

Schat KA, Pratt WD, Morgan R, Weinstock D, Calnek BW.

Avian Dis. 1992 Apr-Jun;36(2):432-9.

PMID:
1320872
12.

Gordon Memorial Lecture. Chicken neoplasia--a model for cancer research.

Calnek BW.

Br Poult Sci. 1992 Mar;33(1):3-16. Review.

PMID:
1315185
13.

Two distinct alpha beta T-cell lineages can be distinguished by the differential usage of T-cell receptor V beta gene segments.

Lahti JM, Chen CL, Tjoelker LW, Pickel JM, Schat KA, Calnek BW, Thompson CB, Cooper MD.

Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10956-60.

14.
15.

Genetic susceptibility of chicken macrophages to in vitro infection with infectious laryngotracheitis virus.

Loudovaris T, Calnek BW, Yoo BH, Fahey KJ.

Avian Pathol. 1991 Jun;20(2):291-302.

PMID:
18680023
16.

Transformation of T-lymphocyte subsets by Marek's disease herpesvirus.

Schat KA, Chen CL, Calnek BW, Char D.

J Virol. 1991 Mar;65(3):1408-13.

17.
18.

Pathogenesis of Marek's disease virus-induced local lesions. 1. Lesion characterization and cell line establishment.

Calnek BW, Lucio B, Schat KA, Lillehoj HS.

Avian Dis. 1989 Apr-Jun;33(2):291-302.

PMID:
2546529
19.

Cytotoxic T lymphocytes in reticuloendotheliosis virus-infected chickens.

Weinstock D, Schat KA, Calnek BW.

Eur J Immunol. 1989 Feb;19(2):267-72.

PMID:
2467812
20.

Immune response versus susceptibility to Marek's disease.

Calnek BW, Adene DF, Schat KA, Abplanalp H.

Poult Sci. 1989 Jan;68(1):17-26.

PMID:
2784854
21.

Maintenance of Marek's disease herpesvirus latency in vitro by a factor found in conditioned medium.

Buscaglia C, Calnek BW.

J Gen Virol. 1988 Nov;69 ( Pt 11):2809-18.

PMID:
2460584
22.

Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus.

Buscaglia C, Calnek BW, Schat KA.

J Gen Virol. 1988 May;69 ( Pt 5):1067-77.

PMID:
2836551
23.

Expression of a putative tumor-associated surface antigen on normal versus Marek's disease virus-transformed lymphocytes.

McColl KA, Calnek BW, Harris WV, Schat KA, Lee LF.

J Natl Cancer Inst. 1987 Nov;79(5):991-1000.

PMID:
3479647
24.

Papovavirus infection in hand-fed parrots: virus isolation and pathology.

Graham DL, Calnek BW.

Avian Dis. 1987 Apr-Jun;31(2):398-410.

PMID:
3619835
25.

Cultured avian lymphocytes with natural killer cell activity.

Schat KA, Calnek BW, Weinstock D.

Prog Clin Biol Res. 1987;238:157-69. No abstract available.

PMID:
3602005
26.

In vitro infection studies with infectious laryngotracheitis virus.

Calnek BW, Fahey KJ, Bagust TJ.

Avian Dis. 1986 Apr-Jun;30(2):327-36.

PMID:
3015117
27.

Cultivation and characterisation of avian lymphocytes with natural killer cell activity.

Schat KA, Calnek BW, Weinstock D.

Avian Pathol. 1986;15(3):539-56.

PMID:
18766553
28.

Peter M. Biggs--an appreciation.

Calnek BW.

Avian Pathol. 1986;15(3):319-22. No abstract available.

PMID:
18766534
30.

Marek's disease--a model for herpesvirus oncology.

Calnek BW.

Crit Rev Microbiol. 1986;12(4):293-320. Review.

PMID:
3007026
31.

Pathogenesis of infection with attenuated Marek's disease virus strains.

Schat KA, Calnek BW, Fabricant J, Graham DL.

Avian Pathol. 1985 Jan;14(1):127-46.

PMID:
18766904
32.

Avian diseases.

Fabricant J, Calnek BW.

Cornell Vet. 1985 Jan;75(1):124-9. No abstract available.

34.

Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection.

Calnek BW, Schat KA, Ross LJ, Chen CL.

Int J Cancer. 1984 Mar 15;33(3):399-406.

PMID:
6321365
35.

Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection.

Calnek BW, Schat KA, Ross LJ, Shek WR, Chen CL.

Int J Cancer. 1984 Mar 15;33(3):389-98.

PMID:
6321364
36.

Pathogenesis of reticuloendotheliosis virus infection in ducks.

Li J, Calnek BW, Schat KA, Graham DL.

Avian Dis. 1983 Oct-Dec;27(4):1090-105.

PMID:
6316895
37.

Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.

Calnek BW, Schat KA, Peckham MC, Fabricant J.

Avian Dis. 1983 Jul-Sep;27(3):844-9.

PMID:
6314982
38.
39.

Characterization of non-oncogenic Marek's disease virus-infected and turkey herpesvirus-infected lymphocytes.

Shek WR, Schat KA, Calnek BW.

J Gen Virol. 1982 Dec;63(2):333-41. No abstract available.

PMID:
6296281
40.

Serological cross-reactivity of avian adenovirus serotypes in an enzyme-linked immunosorbent assay.

Calnek BW, Shek WR, Menendez NA, Stiube P.

Avian Dis. 1982 Oct-Dec;26(4):897-906.

PMID:
6297452
41.

Surface antigens on Marek's disease lymphoblastoid tumor cell lines.

Schat KA, Chen CL, Shek WR, Calnek BW.

J Natl Cancer Inst. 1982 Sep;69(3):715-20.

PMID:
6955560
42.

In vitro infection of lymphocytes with Marek's disease virus.

Calnek BW, Schat KA, Shek WR, Chen CL.

J Natl Cancer Inst. 1982 Sep;69(3):709-13.

PMID:
6287084
43.
44.

The early pathogenesis of turkey herpesvirus infection in chickens and turkeys.

Fabricant J, Calnek BW, Schat KA.

Avian Dis. 1982 Apr-Jun;26(2):257-64.

PMID:
6285877
45.

Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines.

Schat KA, Shek WR, Calnek BW, Abplanalp H.

Int J Cancer. 1982 Feb 15;29(2):187-94.

PMID:
6277809
46.

Characterisation of two highly oncogenic strains of Marek's disease virus.

Schat KA, Calnek BW, Fabricant J.

Avian Pathol. 1982;11(4):593-605.

PMID:
18770225
47.

Correction in identification of a coronavirus-like agent isolated from parrots.

Hirai K, Hitchner SB, Calnek BW.

Avian Dis. 1982 Jan-Mar;26(1):169-70. No abstract available.

PMID:
7092738
48.

Marek's disease vaccines.

Calnek BW.

Dev Biol Stand. 1982;52:401-5.

PMID:
6299850
49.

Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance.

Schat KA, Calnek BW, Fabricant J, Abplanalp H.

Poult Sci. 1981 Dec;60(12):2559-66.

PMID:
6283507
50.

Supplemental Content

Loading ...
Support Center